JPET Assistant Professor of Medicine (Clinician-Educator)

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Wang, Y.
Right arrow Articles by White, T. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wang, Y.
Right arrow Articles by White, T. D.

Vol. 285, Issue 1, 105-109, April 1998

Effect of Protein Kinase C Activation on N-Methyl-D-Aspartate-Evoked Release of Adenosine and [3H]Norepinephrine from Rat Cortical Slices1

Yushan Wang and Thomas D. White

Department of Pharmacology, Dalhousie University, Halifax, Nova Scotia, Canada

The role of protein kinase C (PKC) in the N-methyl-D-aspartate (NMDA)-evoked release of adenosine (ADO) and [3H]norepinephrine (NE) from slices of rat parietal cortex was studied. In the absence of Mg++, the PKC activator phorbol 12-myristate 13-acetate (1 µM, PMA) did not release either ADO or [3H]NE, but it potentiated the release of ADO evoked by 20 µM NMDA and the release of [3H]NE evoked by 100 µM NMDA. These potentiating effects of PMA on the NMDA-evoked release of ADO and [3H]NE were reversed by the PKC inhibitor GF109,203X (1 µM). GF109,203X by itself had no effect on the NMDA-evoked release of either ADO or [3H]NE. In the presence of Mg++, PMA did not permit the NMDA-evoked release of [3H]NE to occur. These results indicate that PKC does not play an essential role in the NMDA-evoked release of either ADO or NE. However, activation of PKC potentiates the release of ADO and NE evoked by submaximal concentrations of NMDA. Activation of PKC will have the effect of increasing the inhibitory threshold provided by released ADO when only a few NMDA receptors are activated and will promote and accelerate excitatory responses when most of the available NMDA receptors become activated.


0022-3565/98/2851-0105$03.00/0
THE JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
Copyright © 1998 by The American Society for Pharmacology and Experimental Therapeutics






Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1998 by the American Society for Pharmacology and Experimental Therapeutics.